Binnopharm Group will start selling two hormonal drugs for the treatment of endometriosis in Russia in May this year, and in the future will consider localization of their production. Now the company is actively building a gynecological portfolio, which will include these and several other drugs. In the coming year, the company plans to launch a total of five retail-oriented products on the Russian market.